E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
The effect of mephentermine sulfate on myocardial oxygen consumption, myocardial efficiency and peripheral vascular resistance.
TL;DR: Under controlled hemodynamic conditions, the administration of the sympathomimetic amine, mephentermine sulfate (wyamine) produces a striking elevation of the ventricular function curve in the isolated supported dog heart and in the dog with an open chest with a complete circulation.
Journal ArticleDOI
Effect of pharmacologic agents on the function of the ischemic heart
TL;DR: Since isoproterenol, tachycardia induced by atrial pacing, propranolol and Hyaluronidase alter the extent and severity of cardiac damage after coronary occlusion, their effects on the function of the severely ischemic heart were studied.
Journal Article
Studies on digitalis. vii. influence of hyper- and hypothyroidism on the myocardial response to ouabain
TL;DR: Observations indicate that while hyper- and hypothyroidism alter the response to ouabain, the three myocardial effects of ouABain were not altered in a uniform manner by changes in the thyroid state.
Journal ArticleDOI
Determinants and assessment of cardiac function.
TL;DR: The purpose of this article is to present relevant definitions and a framework for understanding these technics so that they can be applied to clinical problems in a rational manner.
Journal ArticleDOI
Ventricular enlargement following infarction is a modifiable process.
Marc A. Pfeffer,Eugene Braunwald +1 more
TL;DR: There is currently a great deal of clinical investigative interest not only in whether ACE inhibition therapy following acute myocardial infarction will result in preservation of ventricular volume and topography, but, more importantly, whether it will lead to an improvement in clinical outcome.